Literature DB >> 21401605

Does hydrophobicity always enhance antioxidant drugs? A cut-off effect of the chain length of functionalized chlorogenate esters on ROS-overexpressing fibroblasts.

Mickaël Laguerre1, Chantal Wrutniak-Cabello, Béatrice Chabi, Luis J López Giraldo, Jérôme Lecomte, Pierre Villeneuve, Gérard Cabello.   

Abstract

OBJECTIVES: Phenolic antioxidants are currently attracting a growing interest as potential therapeutic agents to counteract diseases associated with oxidative stress. However, their high hydrophilicity results in a poor bioavailability hindering the development of efficient antioxidant strategies. A promising way to overcome this is to increase their hydrophobicity by lipophilic moiety grafting to form the newly coined 'phenolipids'. Although hydrophobicity is generally considered as advantageous regarding antioxidant properties, it is nevertheless worth investigating whether increasing hydrophobicity necessarily leads to a more efficient antioxidant drug.
METHODS: To answer this question, the antioxidant capacity of a homologous series of phenolics (chlorogenic acid and its methyl, butyl, octyl, dodecyl and hexadecyl esters) toward mitochondrial reactive oxygen species (ROS) generated in a ROS-overexpressing fibroblast cell line was investigated using 2',7'-dichlorodihydrofluorescein. KEY
FINDINGS: Overall, the long chain esters (dodecyl and hexadecyl esters) were more active than the short ones (methyl, butyl, and octyl esters), with an optimal activity for dodecyl chlorogenate. Moreover, dodecyl chlorogenate exerted a strong antioxidant capacity, for concentration and incubation time below the cytotoxicity threshold, making it a promising candidate for further in-vivo studies. More importantly, we found that the elongation of the chain length from 12 to 16 carbons led unexpectedly to a 45% decrease of antioxidant capacity.
CONCLUSION: The understanding of this sudden collapse of the antioxidant capacity through the cut-off theory will be discussed in this article, and may contribute towards development of a rational approach to design novel amphiphilic antioxidant drugs, especially phenolipids with medium fatty chain.
© 2011 The Authors. JPP © 2011 Royal Pharmaceutical Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21401605     DOI: 10.1111/j.2042-7158.2010.01216.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  5 in total

1.  Boosting antioxidants by lipophilization: a strategy to increase cell uptake and target mitochondria.

Authors:  Christelle Bayrasy; Béatrice Chabi; Mickaël Laguerre; Jérôme Lecomte; Elodie Jublanc; Pierre Villeneuve; Chantal Wrutniak-Cabello; Gérard Cabello
Journal:  Pharm Res       Date:  2013-04-19       Impact factor: 4.200

2.  Evaluation of the ROS Inhibiting Activity and Mitochondrial Targeting of Phenolic Compounds in Fibroblast Cells Model System and Enhancement of Efficiency by Natural Deep Eutectic Solvent (NADES) Formulation.

Authors:  Erwann Durand; Jérôme Lecomte; Rashmi Upasani; Béatrice Chabi; Christelle Bayrasy; Bruno Baréa; Elodie Jublanc; Martyn J Clarke; David J Moore; Jonathan Crowther; Chantal Wrutniak-Cabello; Pierre Villeneuve
Journal:  Pharm Res       Date:  2017-02-21       Impact factor: 4.200

3.  Long Chain Fatty Acid Esters of Quercetin-3-O-glucoside Attenuate H₂O₂-induced Acute Cytotoxicity in Human Lung Fibroblasts and Primary Hepatocytes.

Authors:  Sumudu N Warnakulasuriya; H P Vasantha Rupasinghe
Journal:  Molecules       Date:  2016-04-06       Impact factor: 4.411

4.  FAHFAs Regulate the Proliferation of C2C12 Myoblasts and Induce a Shift toward a More Oxidative Phenotype in Mouse Skeletal Muscle.

Authors:  Melha Benlebna; Laurence Balas; Laurence Pessemesse; Béatrice Bonafos; Gilles Fouret; Laura Pavlin; Bénédicte Goustard; Sylvie Gaillet; Thierry Durand; Charles Coudray; Christine Feillet-Coudray; François Casas
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

5.  SIRT3, a mitochondrial NAD⁺-dependent deacetylase, is involved in the regulation of myoblast differentiation.

Authors:  Waed Abdel Khalek; Fabienne Cortade; Vincent Ollendorff; Laure Lapasset; Lionel Tintignac; Béatrice Chabi; Chantal Wrutniak-Cabello
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.